Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, the royalty obligations of this Section 5.4 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by payable on the Product incorporating such Compound).
Appears in 2 contracts
Samples: License and Collaboration Agreement (Newlink Genetics Corp), License and Collaboration Agreement (Newlink Genetics Corp)
Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, the royalty obligations of this Section 5.4 5.5 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by be payable on the Product incorporating such Compound).
Appears in 2 contracts
Samples: Research Collaboration, Option and Exclusive License Agreement (Ambrx Inc), Research Collaboration, Option and Exclusive License Agreement (Ambrx Inc)
Royalties for Bulk Compound. In those cases in which where Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, such sale shall be made in an arm’s length transaction and the royalty obligations of this Section 5.4 5.13 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by payable on the Product incorporating such Compound).
Appears in 2 contracts
Samples: Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, the royalty obligations of this Section 5.4 5.3 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by be payable on the Product incorporating such Compound).
Appears in 2 contracts
Samples: Collaboration and Exclusive License Agreement (Chimerix Inc), Collaboration and Exclusive License Agreement (Chimerix Inc)
Royalties for Bulk Compound. In those cases in which where Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, such sale shall be made in an arm's length transaction and the royalty obligations of this Section 5.4 5.13 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by payable on the Product incorporating such Compound).
Appears in 2 contracts
Samples: Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma), Exclusive Research Collaboration, License and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Royalties for Bulk Compound. In those cases in which where Merck (or its Related Party) sells --------------------------- bulk Compound Substance rather than Licensed Product in packaged form to an independent Third Partythird party, the royalty obligations of this Section 5.4 Article IV shall be applicable to the bulk Compound only (but solely Substance, except in the event the third party, directly or indirectly, sells such Substance back to the extent that a royalty would otherwise by payable on the Product incorporating such Compound)Merck.
Appears in 1 contract
Samples: License Agreement (Cytrx Corp)
Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound Product Candidate rather than Licensed Product in packaged form to an independent Third Party, the royalty obligations of this Section 5.4 5.3 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by payable on the Product incorporating such Compound)Candidate.
Appears in 1 contract
Samples: Research Collaboration and Exclusive License Agreement (Foghorn Therapeutics Inc.)
Royalties for Bulk Compound. In those cases in which where Merck (or its Related Party) sells bulk Compound ----------------------------- Substance rather than Licensed Product in packaged form to an independent Third Partythird party, the royalty obligations of this Section 5.4 Article IV shall be applicable to the bulk Compound only (but solely Substance, except in the event the third party, directly or indirectly, sells such Substance back to the extent that a royalty would otherwise by payable on the Product incorporating such Compound)Merck.
Appears in 1 contract
Samples: License Agreement (Cytrx Corp)
Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, the royalty obligations of this Section 5.4 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by be payable on the Product incorporating such Compound).
Appears in 1 contract
Samples: Research Collaboration and License Agreement (Bionomics Limited/Fi)
Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound rather than Licensed Product in packaged form to an independent Third PartyParty who is not a sublicensee hereunder, the royalty obligations of this Section 5.4 6.4 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by payable on the Product incorporating such Compound).
Appears in 1 contract
Samples: Research Collaboration and Exclusive License Agreement (Janux Therapeutics, Inc.)
Royalties for Bulk Compound. In those cases in which where Merck (or its Related Party) sells bulk Compound ---------------------------- Substance rather than Licensed Product in packaged form to an independent Third Partythird party, the royalty obligations of this Section 5.4 Article IV shall be applicable to the bulk Compound only (but solely Substance, except in the event the third party, directly or indirectly, sells such Substance back to the extent that a royalty would otherwise by payable on the Product incorporating such Compound)Merck.
Appears in 1 contract
Samples: License Agreement (Cytrx Corp)
Royalties for Bulk Compound. In those cases in which Merck (or its Related Party) sells bulk Compound rather than Product in packaged form to an independent Third Party, the royalty obligations of this Section 5.4 shall be applicable to the bulk Compound only (but solely to the extent that a royalty would otherwise by payable on the Product incorporating such Compound)sales.
Appears in 1 contract
Samples: Exclusive License and Research Collaboration Agreement (Cocrystal Pharma, Inc.)